Using breast, pancreas, lung, colorectal and liver cancer models, we and others have demonstrated that silencing SATB2 expression by shRNA or Crisp/Cas9 significantly inhibited cell proliferation, and colony formation of various cancer cells.7, 8, 9, 22, 23, 24. Here, SATB2 is linked to cancer.